Potential target for multiple sclerosis therapy discovered
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...
WebMD2y
Multiple Sclerosis Resource Center
Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...
Baylor College of Medicine4y
Multiple Sclerosis
At Baylor Medicine's Maxine Mesinger Multiple Sclerosis Clinic specialized physicians provide diagnostics, treatment and support services to MS patients at a single, easy access location. Our ...